MED SANTE

UC San Francisco scientists have discovered that muscle repair requires the action of two types of cells better known for causing inflammation and forming fat. The finding in mice, published in the April 11 issue of Cell, showed that a well-known immune...

Researchers at UT Southwestern Medical Center have found that alternative splicing – a process that allows a single gene to code for multiple proteins – appears to be a new potential target for anti-telomerase cancer therapy. The enzyme telomerase is...

For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment. Whether this mental “fogginess” is psychosomatic or reflects underlying changes in brain...

It makes sense, doesn’t it? If you’re at all like me and everyone else I know, there’s always one more thing that you want – or need – to make your life feel complete. Yet Phillips says that we… http://healthmedicinet.com/i/a-simple-technique-for-fee...

The recent defeat of all efforts at gun control is shocking, given the fact that 90 percent of Americans supported the measures. How could that happen? The key is the power of self-interest. It… http://healthmedicinet.com/i/guns-and-the-self-interest...

In this respect the Tsarnaev brothers were drawn into the creative mania that brought Barnum and Bailey to your town, or planned the Roman amphitheater’s gala gladiatorial combats, criminal… http://healthmedicinet.com/i/run-for-your-life/

Advisors to the US Food and Drug Administration have given the thumbs up to GlaxoSmithKline/Theravance’s chronic obstructive pulmonary disease (COPD) inhaler Breo Ellipta, leaving the product just a hair’s breadth away from approval for the all-important...

US Democrats have this week introduced legislation into Congress that would require drugmakers to provide rebates to the government on prescription drugs used by people enrolled in both the Medicare prescription drug (Part D) and Medicaid health programmes....

Regulators in the USA have made it easier for Vivus to sell its diet pill Qsymia but the firm is again being urged to sign a partnering deal with big pharma if the drug is to be a blockbuster. In September, Qsymia (phentermine/topiramate) became the first...

It looks as though Elan Corp has beaten off the advances of Royalty Pharma after the Irish drugmaker’s previously-announced buyback saw shareholders tender stock at a lower price than the US would-be acquirer had advised. At the beginning of the week,...